Rong Tu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rong Tu has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Size Wu
Department of Ultrasound, The First Affiliated Hospital of Hainan Medical University, Haikou 570102, Hainan Province, China.
5 shared publications - Size Wu
Department of Medical Imaging, Affiliated Hospital of Hainan Medical College, Haikou, China
4 shared publications Guangqing Liu
Department of Ultrasound, Affiliated Hospital of Hainan Medical College, Haikou, China
3 shared publications- Guangqing Liu
Department of Medical Imaging, Affiliated Hospital of Hainan Medical College, No. 31, Longhua Road, Haikou, 570102, China
3 shared publications - Xian Liang
Department of Ultrasound, Affiliated Hospital of Hainan Medical College, Haikou, China
2 shared publications Yusen Shi
Department of Medical Imaging, Affiliated Hospital of Hainan Medical College, Haikou, China
2 shared publications
Latest Publications
- 1 November 2022
- Published by American Scientific Publishers in Journal of Biomedical Nanotechnology
- Vol. 18 (11) , 2470-2478
Gadolinium-Based MRI Contrast Agent for Targeted Imaging of Vascular Endothelial Growth Factor Receptor-2-Expressing Tumors
Development of imaging methods that can detect target molecules will be of great significance for non-invasive molecular diagnosis. Vascular endothelial growth factor receptor-2 (VEGFR-2) is a broadly expressed target, and VEGFR-2-specific agents have been used in biological therapy. In this study, amine-reactive coupling was used to label the polypeptide VEGF125–136 with a Gd(DOTA) complex to create a magnetic resonance contrast agent, VEGF125–136-Gd, which binds to VEGFR-2. Using T1-weighted magnetic resonance imaging, we explored the tumor cell-targeting ability of VEGF125–136-Gd and its enhancement of T1-weighted image intensity using human hepatoma (HepG2) cells and found that the signal-to-noise ratio (SNR) increased commensurately with the concentration of VEGF125–136-Gd. At a concentration of 2 mM, the SNR produced by VEGF125–136-Gd was 5.4-fold higher than that produced by a Gd-labelled non-targeting polypeptide (NTPP-Gd) control. We also evaluated the tumor-targeting efficiency of VEGF125–136-Gd in nude mice injected with human hepatoma (HepG2) cells. Preliminary in vivo imaging of VEGFR-2 in tumor tissue revealed a targeting peak 60 min post administration of VEGF125–136-Gd, the intensity of which was 23% higher than the SNR of NTPP-Gd at the same time point. Our findings may help lay the foundation for clinical applications of VEGF125–136-Gd in targeted imaging.
- 1 November 2022
- Published by American Scientific Publishers in Journal of Biomedical Nanotechnology
- Vol. 18 (11) , 2470-2478
Gadolinium-Based MRI Contrast Agent for Targeted Imaging of Vascular Endothelial Growth Factor Receptor-2-Expressing Tumors
Development of imaging methods that can detect target molecules will be of great significance for non-invasive molecular diagnosis. Vascular endothelial growth factor receptor-2 (VEGFR-2) is a broadly expressed target, and VEGFR-2-specific agents have been used in biological therapy. In this study, amine-reactive coupling was used to label the polypeptide VEGF125–136 with a Gd(DOTA) complex to create a magnetic resonance contrast agent, VEGF125–136-Gd, which binds to VEGFR-2. Using T1-weighted magnetic resonance imaging, we explored the tumor cell-targeting ability of VEGF125–136-Gd and its enhancement of T1-weighted image intensity using human hepatoma (HepG2) cells and found that the signal-to-noise ratio (SNR) increased commensurately with the concentration of VEGF125–136-Gd. At a concentration of 2 mM, the SNR produced by VEGF125–136-Gd was 5.4-fold higher than that produced by a Gd-labelled non-targeting polypeptide (NTPP-Gd) control. We also evaluated the tumor-targeting efficiency of VEGF125–136-Gd in nude mice injected with human hepatoma (HepG2) cells. Preliminary in vivo imaging of VEGFR-2 in tumor tissue revealed a targeting peak 60 min post administration of VEGF125–136-Gd, the intensity of which was 23% higher than the SNR of NTPP-Gd at the same time point. Our findings may help lay the foundation for clinical applications of VEGF125–136-Gd in targeted imaging.
- Open Access
- 1 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1)
Growing Evidence of Exosomal MicroRNA‐Related Metastasis of Hepatocellular Carcinoma
Metastasis is the prominent cause of death in patients with hepatocellular carcinoma (HCC); however, the mechanisms behind HCC metastasis are not well understood. MicroRNAs (miRs) can regulate gene expression and affect HCC metastasis. Exosomes can transport miRs and other cargoes to and from different cells, thus being associated with tumour‐distant metastasis. Exosomal miRs involve different processes of HCC metastasis through their functional effects, such as their induction of epithelial‐to‐mesenchymal transition, angiogenesis, and distant niche. In this review, data from the literature were analysed and summarised, with a focus on the evidence extraction of exosomal miRs in HCC metastasis with the purpose of increasing the understanding of the mechanisms behind HCC metastasis and acquiring implications for application.
- 1 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1)
Open AccessGrowing Evidence of Exosomal MicroRNA‐Related Metastasis of Hepatocellular Carcinoma
Metastasis is the prominent cause of death in patients with hepatocellular carcinoma (HCC); however, the mechanisms behind HCC metastasis are not well understood. MicroRNAs (miRs) can regulate gene expression and affect HCC metastasis. Exosomes can transport miRs and other cargoes to and from different cells, thus being associated with tumour‐distant metastasis. Exosomal miRs involve different processes of HCC metastasis through their functional effects, such as their induction of epithelial‐to‐mesenchymal transition, angiogenesis, and distant niche. In this review, data from the literature were analysed and summarised, with a focus on the evidence extraction of exosomal miRs in HCC metastasis with the purpose of increasing the understanding of the mechanisms behind HCC metastasis and acquiring implications for application.
- Open Access
- 1 October 2019
- Published by Korean Society of Ultrasound in Medicine in Ultrasonography
- Vol. 38 (4) , 327-335
Patchy echogenicity of the liver in patients with chronic hepatitis B does not indicate poorer elasticity
Purpose: This study was conducted to investigate whether the presence of patchy echogenicity in the liver of patients with chronic hepatitis B (CHB) is predictive of liver stiffness. Methods: A total of 200 CHB patients with and without patchy echogenicity of the liver were assigned to two groups, with 100 patients in each group, and 32 of them underwent liver biopsy. Additionally, 80 healthy subjects, 100 inactive hepatitis B virus (HBV) carriers, and 100 patients with decompensated hepatic cirrhosis were assigned to the control groups. Laboratory tests and clinical data were collected, and shear wave velocity (SWV) of the liver was measured for all 480 subjects. Results: The median SWV in patients with a normal liver, inactive HBV carriers, CHB patients with and without patchy echogenicity, and decompensated hepatic cirrhosis were 1.07 m/sec, 1.08 m/sec, 1.16 m/sec, 1.16 m/sec, and 2.02 m/sec, respectively; there was no significant difference in SWV values between CHB patients with patchy echogenicity and those without patchy echogenicity. Furthermore, among CHB patients with and without patchy echogenicity, no significant difference in SWV was found according to fibrosis stage. Conclusion: The presence of patchy echogenicity of the liver does not indicate a higher degree of liver stiffness.
- 1 October 2019
- Published by Korean Society of Ultrasound in Medicine in Ultrasonography
- Vol. 38 (4) , 327-335
Open AccessPatchy echogenicity of the liver in patients with chronic hepatitis B does not indicate poorer elasticity
Purpose: This study was conducted to investigate whether the presence of patchy echogenicity in the liver of patients with chronic hepatitis B (CHB) is predictive of liver stiffness. Methods: A total of 200 CHB patients with and without patchy echogenicity of the liver were assigned to two groups, with 100 patients in each group, and 32 of them underwent liver biopsy. Additionally, 80 healthy subjects, 100 inactive hepatitis B virus (HBV) carriers, and 100 patients with decompensated hepatic cirrhosis were assigned to the control groups. Laboratory tests and clinical data were collected, and shear wave velocity (SWV) of the liver was measured for all 480 subjects. Results: The median SWV in patients with a normal liver, inactive HBV carriers, CHB patients with and without patchy echogenicity, and decompensated hepatic cirrhosis were 1.07 m/sec, 1.08 m/sec, 1.16 m/sec, 1.16 m/sec, and 2.02 m/sec, respectively; there was no significant difference in SWV values between CHB patients with patchy echogenicity and those without patchy echogenicity. Furthermore, among CHB patients with and without patchy echogenicity, no significant difference in SWV was found according to fibrosis stage. Conclusion: The presence of patchy echogenicity of the liver does not indicate a higher degree of liver stiffness.
- 5 December 2018
- Published by Springer Nature in Multimedia Tools and Applications
- Vol. 78 (7) , 8463-8480
Contourlet-DCT based multiple robust watermarkings for medical images
- 5 December 2018
- Published by Springer Nature in Multimedia Tools and Applications
- Vol. 78 (7) , 8463-8480
Contourlet-DCT based multiple robust watermarkings for medical images
- Open Access
- 1 January 2016
- Published by Korean Society of Ultrasound in Medicine in Ultrasonography
- Vol. 35 (1) , 39-46
Impact of variations in fatty liver on sonographic detection of focal hepatic lesions originally identified by CT
The aim of this study was to investigate the influence of variations in fatty liver on the ultrasonographic detection of focal liver lesions. A total of 229 patients with varying degrees of fatty liver and focal liver lesions and 200 patients with focal liver lesions but no fatty liver were randomly selected for inclusion in groups I and II, respectively. Findings of focal liver lesions identified on computed tomography were taken as the reference, and findings on ultrasonography were compared with them. The number of focal liver lesions in groups I and II were 501 and 413, respectively. The ultrasonographic detection rates of focal liver lesions in groups I and II were 86.8% (435/501) and 94.2% (389/413), respectively. Comparison of the detection of the focal lesions between patients with and without fatty liver or different grades of fatty liver were as follows: mild fatty liver (162/177) vs. liver without fat infiltration (389/413) (P=0.277); mild fatty liver (162/177) vs. moderate fatty liver (190/212) (P=0.604); mild fatty liver (162/177) vs. severe fatty liver (83/112) (P<0.001); moderate fatty liver (190/212) vs. liver without fat infiltration (389/413) (P=0.051); moderate fatty liver (190/212) vs. severe fatty liver (83/112) (P<0.001); severe fatty liver (83/112) vs. liver without fat infiltration (389/413) (P<0.001); and fatty liver (435/501) vs. liver without fat infiltration (389/413) (P<0.001). Mild and moderate fatty liver are not significantly associated with the visualization of the lesion, while severe fatty liver usually impairs the detection of focal lesions in the liver. If a patient with severe fatty liver is suspected to have a liver tumor, ultrasonography should only be chosen cautiously in case of a missed diagnosis.
- 1 January 2016
- Published by Korean Society of Ultrasound in Medicine in Ultrasonography
- Vol. 35 (1) , 39-46
Open AccessImpact of variations in fatty liver on sonographic detection of focal hepatic lesions originally identified by CT
The aim of this study was to investigate the influence of variations in fatty liver on the ultrasonographic detection of focal liver lesions. A total of 229 patients with varying degrees of fatty liver and focal liver lesions and 200 patients with focal liver lesions but no fatty liver were randomly selected for inclusion in groups I and II, respectively. Findings of focal liver lesions identified on computed tomography were taken as the reference, and findings on ultrasonography were compared with them. The number of focal liver lesions in groups I and II were 501 and 413, respectively. The ultrasonographic detection rates of focal liver lesions in groups I and II were 86.8% (435/501) and 94.2% (389/413), respectively. Comparison of the detection of the focal lesions between patients with and without fatty liver or different grades of fatty liver were as follows: mild fatty liver (162/177) vs. liver without fat infiltration (389/413) (P=0.277); mild fatty liver (162/177) vs. moderate fatty liver (190/212) (P=0.604); mild fatty liver (162/177) vs. severe fatty liver (83/112) (P<0.001); moderate fatty liver (190/212) vs. liver without fat infiltration (389/413) (P=0.051); moderate fatty liver (190/212) vs. severe fatty liver (83/112) (P<0.001); severe fatty liver (83/112) vs. liver without fat infiltration (389/413) (P<0.001); and fatty liver (435/501) vs. liver without fat infiltration (389/413) (P<0.001). Mild and moderate fatty liver are not significantly associated with the visualization of the lesion, while severe fatty liver usually impairs the detection of focal lesions in the liver. If a patient with severe fatty liver is suspected to have a liver tumor, ultrasonography should only be chosen cautiously in case of a missed diagnosis.
- Open Access
- 1 October 2013
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 32 (10) , 1695-1702
Findings and Implications of Focal Fatty Sparing of the Liver at Follow‐up
Objectives The purpose of this study was to investigate the stability of focal fatty sparing of the liver and its clinical implications. Methods This prospective study consisted of 2 parts. In the first part, patients who underwent sonography and computed tomography (CT) or magnetic resonance imaging (MRI) were selected, and abnormal findings including focal and diffuse liver abnormalities were documented. In the second part, patients with nonalcoholic hepatic steatosis and focal fatty sparing were included and underwent follow‐up with sonography in the second and third years (study interval, 34–37 months; mean ± SD, 35.9 ± 1.14 months). Some cases of focal fatty sparing that were not appreciable on sonography in the third year were reevaluated with CT. Results A total of 6781 patients with nonalcoholic hepatic steatosis and focal abnormalities were found among 35,337 people undergoing liver sonography; 2133 underwent CT, MRI, biopsy, or a combination thereof. Eighty‐nine of those patients (63 male and 26 female; mean age, 37.6 ± 17.5 years; range, 18–72 years) with hepatic steatosis and focal fatty sparing were finally included. In the second part of the study, focal fatty sparing was appreciable on follow‐up sonography in 78 cases (87.6%) and 61 cases (68.5%) in the second and third years, respectively. The hepatic steatosis resolved in the third year in 4 patients, and 26 of 28 cases (92.8%) of focal fatty sparing that were not appreciable on follow‐up sonography were found on CT in the third year. Conclusions Focal fatty sparing may change with fatty liver changes over time, and it is sometimes not appreciable on sonography, although it is often evident on CT. These findings imply that if differentiation between focal fatty sparing and a tumor is undetermined and follow‐up is performed, should any change occur, then an abnormality that is no longer appreciable at follow‐up is probably focal fatty sparing rather than a true tumor.
- 1 October 2013
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 32 (10) , 1695-1702
Open AccessFindings and Implications of Focal Fatty Sparing of the Liver at Follow‐up
Objectives The purpose of this study was to investigate the stability of focal fatty sparing of the liver and its clinical implications. Methods This prospective study consisted of 2 parts. In the first part, patients who underwent sonography and computed tomography (CT) or magnetic resonance imaging (MRI) were selected, and abnormal findings including focal and diffuse liver abnormalities were documented. In the second part, patients with nonalcoholic hepatic steatosis and focal fatty sparing were included and underwent follow‐up with sonography in the second and third years (study interval, 34–37 months; mean ± SD, 35.9 ± 1.14 months). Some cases of focal fatty sparing that were not appreciable on sonography in the third year were reevaluated with CT. Results A total of 6781 patients with nonalcoholic hepatic steatosis and focal abnormalities were found among 35,337 people undergoing liver sonography; 2133 underwent CT, MRI, biopsy, or a combination thereof. Eighty‐nine of those patients (63 male and 26 female; mean age, 37.6 ± 17.5 years; range, 18–72 years) with hepatic steatosis and focal fatty sparing were finally included. In the second part of the study, focal fatty sparing was appreciable on follow‐up sonography in 78 cases (87.6%) and 61 cases (68.5%) in the second and third years, respectively. The hepatic steatosis resolved in the third year in 4 patients, and 26 of 28 cases (92.8%) of focal fatty sparing that were not appreciable on follow‐up sonography were found on CT in the third year. Conclusions Focal fatty sparing may change with fatty liver changes over time, and it is sometimes not appreciable on sonography, although it is often evident on CT. These findings imply that if differentiation between focal fatty sparing and a tumor is undetermined and follow‐up is performed, should any change occur, then an abnormality that is no longer appreciable at follow‐up is probably focal fatty sparing rather than a true tumor.
- 3 September 2013
- Published by Springer Nature in Journal of Medical Ultrasonics
- Vol. 41 (2) , 165-171
Dynamic changes in ultrasound characteristics of nodules in cirrhotic liver and their implications in surveillance for malignancy
- 3 September 2013
- Published by Springer Nature in Journal of Medical Ultrasonics
- Vol. 41 (2) , 165-171
Dynamic changes in ultrasound characteristics of nodules in cirrhotic liver and their implications in surveillance for malignancy
- 26 April 2013
- Published by Springer Nature in Journal of Medical Ultrasonics
- Vol. 40 (4) , 425-428
Approach to improving sonographic visualization of elongated left lobe of the liver and its implications
Purpose To determine whether visualization of the elongated left lobe of the liver can be improved by distending the stomach with water and the implications of this technique. Methods Forty-three out of 87 patients with elongated left lobe of the liver found at abdominal CT were included in this study after obtaining informed consent. Their livers were examined using ultrasound before and after drinking water. The left lobe of the liver was scanned from the subxiphoid and left subcostal approaches, with the sound beam directed to the spleen and the left lobe of the liver neighboring or behind the stomach; the elongated left lobe of the liver overlying the spleen was detected by scanning from the 9th–11th intercostal approach of the left flank. Results The overall visualization of the elongated left lobe of the liver before and after filling the stomach with water was 4.7 % (2/43) and 100.0 % (43/43), respectively (P < 0.001); and the overall visualization of the spleen before and after filling the stomach with water was 4.7 % (2/43) and 100.0 % (43/43), respectively (P < 0.001). Conclusion Distending the stomach with sufficient water can substantially improve visualization of elongated left lobe of the liver at ultrasound, potentially improving detection of tumors in the liver and preventing misdiagnosis.
- 26 April 2013
- Published by Springer Nature in Journal of Medical Ultrasonics
- Vol. 40 (4) , 425-428
Approach to improving sonographic visualization of elongated left lobe of the liver and its implications
Purpose To determine whether visualization of the elongated left lobe of the liver can be improved by distending the stomach with water and the implications of this technique. Methods Forty-three out of 87 patients with elongated left lobe of the liver found at abdominal CT were included in this study after obtaining informed consent. Their livers were examined using ultrasound before and after drinking water. The left lobe of the liver was scanned from the subxiphoid and left subcostal approaches, with the sound beam directed to the spleen and the left lobe of the liver neighboring or behind the stomach; the elongated left lobe of the liver overlying the spleen was detected by scanning from the 9th–11th intercostal approach of the left flank. Results The overall visualization of the elongated left lobe of the liver before and after filling the stomach with water was 4.7 % (2/43) and 100.0 % (43/43), respectively (P < 0.001); and the overall visualization of the spleen before and after filling the stomach with water was 4.7 % (2/43) and 100.0 % (43/43), respectively (P < 0.001). Conclusion Distending the stomach with sufficient water can substantially improve visualization of elongated left lobe of the liver at ultrasound, potentially improving detection of tumors in the liver and preventing misdiagnosis.
- 12 April 2013
- Published by Springer Nature in Journal of Medical Ultrasonics
- Vol. 40 (4) , 393-398
Frequency and implication of focal fatty sparing in segmental homogeneous fatty liver at ultrasound
Purpose The purpose of this study was to investigate whether focal fatty sparing arises from preexisting segmental homogeneous nonalcoholic fatty liver (NAFL). Methods Patients with various patterns of fatty liver were recruited from among 16,127 people, and 132 participants with segmental homogeneous NAFL were followed during the second year. All participants underwent ultrasonography. The sonographic findings in segmental homogeneous NAFL were analyzed. Results Of the 16,127 participants, 1,619 had fatty liver (10.0 %), and of these 1,568 had NAFL (9.72 %) and 51 had alcoholic fatty liver (0.31 %). Of the 1,568 patients with NAFL, 176 had homogeneous fatty liver with focal fatty sparing (11.2 %), 132 had segmental homogeneous fatty liver (8.42 %), and the rest had other patterns. At follow-up, of the 132 patients with segmental homogeneous fatty liver, 3 (2.3 %) were found to have a normal liver and 26 (19.7 %) diffuse homogeneous and heterogeneous fatty liver, and no focal fatty sparing was found (P < 0.001). Conclusions Focal fatty sparing usually does not arise in preexisting segmental homogeneous NAFL. This implies that newly appearing nodular hypoechogenicity in segmental homogeneous fatty liver is more likely to be a true lesion rather than focal fatty sparing.
- 12 April 2013
- Published by Springer Nature in Journal of Medical Ultrasonics
- Vol. 40 (4) , 393-398
Frequency and implication of focal fatty sparing in segmental homogeneous fatty liver at ultrasound
Purpose The purpose of this study was to investigate whether focal fatty sparing arises from preexisting segmental homogeneous nonalcoholic fatty liver (NAFL). Methods Patients with various patterns of fatty liver were recruited from among 16,127 people, and 132 participants with segmental homogeneous NAFL were followed during the second year. All participants underwent ultrasonography. The sonographic findings in segmental homogeneous NAFL were analyzed. Results Of the 16,127 participants, 1,619 had fatty liver (10.0 %), and of these 1,568 had NAFL (9.72 %) and 51 had alcoholic fatty liver (0.31 %). Of the 1,568 patients with NAFL, 176 had homogeneous fatty liver with focal fatty sparing (11.2 %), 132 had segmental homogeneous fatty liver (8.42 %), and the rest had other patterns. At follow-up, of the 132 patients with segmental homogeneous fatty liver, 3 (2.3 %) were found to have a normal liver and 26 (19.7 %) diffuse homogeneous and heterogeneous fatty liver, and no focal fatty sparing was found (P < 0.001). Conclusions Focal fatty sparing usually does not arise in preexisting segmental homogeneous NAFL. This implies that newly appearing nodular hypoechogenicity in segmental homogeneous fatty liver is more likely to be a true lesion rather than focal fatty sparing.
- 1 December 2012
- Vol. 14 (4) , 278-82
The frequency and clinical significance of the halo sign in focal nodular hyperplasia of the liver.
The purpose of this study was to investigate the frequency of the halo sign in focal nodular hyperplasia (FNH) of the liver and its clinical significance. Archives of 19 patients (6 men, mean age 35 years +/- 11, range 22-53 years and 13 women, mean age 39 years +/- 15, range 17-66 years) diagnosed from April 2005 through March 2012 with FNH were reviewed. All images were analyzed by three readers in a panel in order to depict the characteristics of the liver lesions and established in consensus a diagnosis. The halo appearance of lesions was focused upon. The halo sign was found in 6 FNHs (31.6%, 6/19). The mean size of the FNHs was 34.2 mm +/- 7.2 (range 23-47 mm). Characteristics of FNH appear were various in gray-scale ultrasound and color Doppler flow imaging, CT and MRI, and combined use of different modalities may enable diagnosis definitely. All patients with FNH reviewed were consistent with previous diagnoses. The halo sign was found in a high number of patients in this study, which implies that the halo sign may be not rare in FNH on sonography, and absence and presence of the halo sign may not help identifying FNH.
- 1 December 2012
- Vol. 14 (4) , 278-82
The frequency and clinical significance of the halo sign in focal nodular hyperplasia of the liver.
The purpose of this study was to investigate the frequency of the halo sign in focal nodular hyperplasia (FNH) of the liver and its clinical significance. Archives of 19 patients (6 men, mean age 35 years +/- 11, range 22-53 years and 13 women, mean age 39 years +/- 15, range 17-66 years) diagnosed from April 2005 through March 2012 with FNH were reviewed. All images were analyzed by three readers in a panel in order to depict the characteristics of the liver lesions and established in consensus a diagnosis. The halo appearance of lesions was focused upon. The halo sign was found in 6 FNHs (31.6%, 6/19). The mean size of the FNHs was 34.2 mm +/- 7.2 (range 23-47 mm). Characteristics of FNH appear were various in gray-scale ultrasound and color Doppler flow imaging, CT and MRI, and combined use of different modalities may enable diagnosis definitely. All patients with FNH reviewed were consistent with previous diagnoses. The halo sign was found in a high number of patients in this study, which implies that the halo sign may be not rare in FNH on sonography, and absence and presence of the halo sign may not help identifying FNH.